Catalyst Wire Dossier Catalyst Wire Dossier

CD2027

· Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD2027, covering 2012-05-01 to 2012-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis [Phase 2]

See pricing